相关实验视频
Updated: Jun 15, 2025
08:02
Combination Radiotherapy in an Orthotopic Mouse Brain Tumor Model
Published on: March 6, 2012
16.4K
在质母细胞瘤-免疫动态模型中的虚拟小鼠队列中,对组合免疫疗法的最佳控制
Hannah G Anderson1, Gregory P Takacs2, Jeffrey K Harrison2
1Department of Mathematics, University of Florida, 1400 Stadium Rd, Gainesville, 32601, FL, USA.
bioRxiv : the preprint server for biology
|August 26, 2024
概括
用抗PD-1和CCR2抗剂优化组合免疫疗法显著改善了小鼠中的质母细胞瘤存活率. 个性化治疗方案提高了生存率,并预测了长期的结果.
科学领域:
- 免疫学 免疫学 免疫学
- 计算生物学 计算生物学
- 在瘤学瘤学.
背景情况:
- 反PD-1免疫疗法作为质母细胞瘤的单一疗法是无效的.
- 在临床前的质母细胞瘤模型中,与CC-化学因子受体-2 (CCR2) 抗剂的联合治疗显示出有前途.
研究的目的:
- 使用最佳控制理论,优化抗PD-1和CCR2抗剂组合免疫治疗质母细胞瘤的治疗方案.
- 评估个性化治疗策略对虚拟小鼠队列生存和生活质量的影响.
主要方法:
- 扩展了质母细胞瘤-免疫动态普通微分方程 (ODE) 模型,以纳入抗PD-1和CCR2抗剂干预措施.
- 应用最佳控制理论来确定最佳的治疗方案.
- 将方法扩展到虚拟的小鼠队列,并进行参数识别分析以进行个性化治疗.
主要成果:
- 优化方案将老鼠的平均存活时间从32天提高到111天.
- 在虚拟队列中,个性化疗法在第100天的生存率为84%,而之前的实验疗法为60%.
- 确定了瘤生长率,T细胞死亡率和MDSC死亡率等因素作为治疗结果的预测因素.
结论:
- 最佳控制理论为优化质母细胞瘤组合免疫治疗提供了一个框架.
- 在质母细胞瘤模型中,个性化治疗策略显著改善了生存结果.
- MDSC死亡率是质母细胞瘤患者生存的关键长期预测指标.
关键词:
34H0505 的时间是 34H0549-11-11 这是一个很好的机会.92-10-10 关于 92-10 的建议数学瘤学数学瘤学优化的优化优化优化.参数可识别性分析 参数可识别性分析个性化治疗 个性化治疗虚拟患者队列是一个虚拟的患者队列.更多相关视频
12:55Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
Published on: February 16, 2015
21.4K
11:15Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts
Published on: September 1, 2018
7.9K
相关概念视频
01:27Tumor Immunotherapy
493
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
493
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K